JKB-121
Metabolic liver disease
PreclinicalActive
Key Facts
About TaiwanJ Pharmaceuticals
TaiwanJ develops small‑molecule drugs for liver and inflammatory diseases using proprietary TLR4/Autotaxin platforms.
View full company profileMetabolic liver disease
TaiwanJ develops small‑molecule drugs for liver and inflammatory diseases using proprietary TLR4/Autotaxin platforms.
View full company profile